Table 5.
Outcome of interest | No. of studies | No.of patients Non-complicated/complicated |
OR/WMD(95%CI) a | p-value | Study heterogeneity | |||
---|---|---|---|---|---|---|---|---|
Chi2 | df | I 2 | p-value | |||||
Guy score | 2 | 263/95 | −0.29[− 0.57,-0.02] | 0.03 | 2.02 | 1 | 51% | 0.15 |
CROES nomogram | 2 | 263/95 | 1.97[−3.77,7.71] | 0.50 | 0.00 | 1 | 0% | 0.96 |
S.T.O.N.E. score | 2 | 263/95 | −0.27[−0.59,0.05] | 0.10 | 0.20 | 1 | 0% | 0.66 |
PCNL percutaneous nephrolithotomy, CROES clinical research office of the endourological society scoring system, Guy Guy scoring system, S.T.O.N.E S.T.O.N.E scoring system, OR odds ratio, WMD weighted mean difference, CI confidence interval, a OR